Heartflow, a cardiac CT AI vendor, files for a $100 million IPO after notable adoption and revenue growth.
Key Details
- 1Heartflow filed SEC documents for a $100M IPO following positive coverage news for its AI CT software.
- 2Radiology benefits manager EviCore and proposed Medicare Fee Schedule support are expected to boost future adoption.
- 3Heartflow's CT-based platform has been used on over 400,000 patients, including 132,000 last year.
- 4Company reported $126 million in revenue for 2023, up 44% year-over-year, but posted a $32.3 million quarterly loss in early 2024.
- 5Market opportunity for Heartflow's AI solutions estimated at $5 billion in the U.S. annually.
- 6IPO proceeds will be used for debt payment, sales, R&D, and general operations.
Why It Matters
Heartflow's IPO marks a major milestone in the maturation of radiology-focused AI companies and demonstrates growing clinical and payer acceptance of imaging AI tools. The public funding and Medicare consideration signal greater integration of AI in CT-based cardiovascular diagnostics.
Source
Radiology Business
Related News
•AuntMinnie
General LLMs Show Promise in Detecting Critical Findings in Radiology Reports
Stanford and Mayo Clinic Arizona researchers demonstrated that LLMs like GPT-4 can categorize critical findings in radiology reports using few-shot prompting.
•AuntMinnie
GE HealthCare Acquires icometrix to Bolster MRI Neurology AI
GE HealthCare is acquiring icometrix to expand its AI-powered MRI neuroimaging capabilities and integrate advanced analytics into its global product ecosystem.
•AuntMinnie
Bayer Shuts Down Calantic and Blackford Radiology AI Platforms
Bayer is discontinuing its Calantic Digital Solutions AI platform and ceasing Blackford Analysis services, signaling a major retreat from the radiology AI platform sector.